Newsletter | September 23, 2024

09.23.24 -- Rare Disease Targeting And Novel Therapy Delivery With Kymanox' Evan Edwards

SPONSOR

Nanotechnology To Improve The Performance Of Your Small And Large Molecule Medicines

Christian Jones shares the latest in nanotechnology advancements including recent clinical data, formulation applications, and API optimization to NanoImprove formulations through superior bioavailability, drug loading, route of administration, pill burden, and more.

FEATURED EDITORIAL

Rare Disease Targeting And Novel Therapy Delivery With Kymanox' Evan Edwards

Commenting on a wide range of therapeutic targets, Kymanox president Evan Edwards joins Supplier Horizons host Tom von Gunden in highlighting opportunities for drug delivery innovation. Front of mind for Evan as he considers areas of advancement are human factors engineering for increased self-administration, targeting rare diseases with novel therapies, and, in general, addressing the challenges of delivering large molecule biologics. 

INDUSTRY INSIGHTS

Deploying A Circular Economy For Injectable Devices

A circular economy prioritizes sustainability throughout the supply chain by eliminating waste, circulating products and materials, and regenerating nature.

Why “Off-The-Shelf” (OTS) Devices Do Not Circumvent Design Controls

Utilizing OTS devices for drug delivery can offer significant advantages to development programs in timeline and risk mitigation. Understand the design control responsibilities of a sponsor.

Emerging Trends And Opportunities In Orally Inhaled Drug Products

From targeting niche diseases to delivering cutting-edge medications, inhaled therapies are poised to become a cornerstone of modern medicine. Explore the intricacies of inhaled drug delivery.

Ensure Speed And Success With Your Drug Delivery Project

Hear from experienced professionals in the drug delivery space on how to ensure success and speed-to-market by establishing a firm foundation when working with a CMO.

Patient-Centric Solutions To Optimize Medication Adherence

Explore how orally disintegrating tablets act as a patient-centric solution to various factors that impact treatment adherence rates across various diseases.

Engineering Approaches To Respiratory Drug Delivery

Review the material and performance properties of spray-dried and jet-milled mannitol for respiratory delivery of crystalline mannitol.

SPONSOR

The FDA Guidance on EDDO: What to Know, What to Do

Join Drug Delivery Leader Executive Editor, Fran DeGrazio, as she engages combination product regulatory experts in a candid conversation about the FDA’s recent draft guidance on Essential Drug Delivery Outputs (EDDO). This dynamic discussion will cover aspects such as design verification, control strategies, human factors, and post-approval changes. Registration is free for this digital event.

SOLUTIONS

Controlled Expansion Of Supercritical Solutions (CESS) Technology

Capacity Update May 2024: Small Molecule APl And HPAPI Development

Aidaptus Auto-Injector Manufacturing

Capacity Update July 2024: Small Molecule Finished Dosage Form